Riccardo Nevola, Maria Alfano, Pia Clara Pafundi, Chiara Brin, Felice Gragnano, Paolo CalabrĂ², Luigi Elio Adinolfi, Luca Rinaldi, Ferdinando Carlo Sasso, Alfredo Caturano
Type 2 Diabetes Mellitus (T2DM) is associated with an elevated incidence of cardiovascular and renal diseases, responsible for mortality rates significantly higher than in the general population. The management of both cardiovascular risk and progression of kidney disease thus seem crucial in the treatment of the diabetic patient. The availability of new classes of drugs which positively affect both cardiovascular and renal risk, regardless of the glycemic control, represents a revolution in the treatment of T2DM and shifts the attention from the intensive glycemic control to a holistic management of the diabetic patient...
March 17, 2022: Reviews in Cardiovascular Medicine